Major themes include: cancer and neurodegenerative diseases systems; and the biology of cancer and neurodegeneration focus on discovery and exploitation of biomarker signatures for clinical applications. The program is single session and consists of plenary, symposium and poster presentations.

All top-quality abstracts and posters that will enrich the perspectives on novel methods for biomarker discovery, their identification and subsequent validation are welcomed.

Abstracts are submitted online. Abstract submission for Selection for Oral/Poster presentation closes on the 28th of August, 2012. Early registration and submission of abstracts is suggested.

You will be notified of Poster/Podium acceptance and a place in the meeting before the close of Early-Bird registration.
Early Bird registration closes on the 27th of September, 2012.